date,title,source
Oct-30-18,Cerecor Receives Rare Pediatric Disease Designation for CERC-801 for Patients with Inborn Error of Metabolism,GlobeNewswire
Oct-31-18,Cerecor Announces Submission of Three Orphan Drug Designation Requests for Substrate Replacement Therapies to treat Congenital Disorders of Glycosylation,GlobeNewswire
Nov-13-18,Cerecor Reports Third Quarter 2018 Results,GlobeNewswire
